Detalles de la búsqueda
1.
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
Oncologist
; 29(4): e514-e525, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38297981
2.
In vitro and in vivo pharmacokinetics, disposition, and drug-drug interaction potential of tinengotinib (TT-00420), a promising investigational drug for treatment of cholangiocarcinoma and other solid tumors.
Eur J Pharm Sci
; 192: 106658, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048851
3.
The first selective VAP-1 inhibitor in China, TT-01025-CL: safety, tolerability, pharmacokinetics, and pharmacodynamics of single- and multiple-ascending doses.
Front Pharmacol
; 15: 1327008, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38741586
4.
Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Triple-Negative Breast Cancer.
Mol Cancer Ther
; 22(2): 205-214, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36223547
5.
Qualitative and quantitative analysis of the major bioactive phenolic compounds of Glechoma longituba by LC-coupled with PAD and ESI-MS detection.
Nat Prod Commun
; 6(1): 17-20, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21366038
6.
UPLC-QTOF/MS-based screening and identification of the constituents and their metabolites in rat plasma and urine after oral administration of Glechoma longituba extract.
J Chromatogr B Analyt Technol Biomed Life Sci
; 878(28): 2741-50, 2010 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20829126
7.
High-performance liquid chromatography--two wavelength detection of triterpenoid acids from the fruits of Ziziphus jujuba containing various cultivars in different regions and classification using chemometric analysis.
J Pharm Biomed Anal
; 49(5): 1296-302, 2009 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-19359121
Resultados
1 -
7
de 7
1
Próxima >
>>